APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Hemostatic Agents

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.

Selected research

Market Structure

Global Medical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchMedical Hemostatic Agents Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Hemostatic Agents Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Medical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Hemostatic Agents Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Hemostatic Agents Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.

North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.

This report provides an overview of the global Medical Hemostatic Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Medical Hemostatic Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Hemostatic Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Hemostatic Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Hemostatic Agents Segment by Company

J&J

Baxter

BD

Gelita

Pfizer

B Braun

CSL Behring

Ferrosan Medical Devices

Advance Medical Solution

Medtronic

Z-Medica

Marine Polymer

Equimedical

CryoLife

Medical Hemostatic Agents Segment by Type

Gelation Hemostats

Combination Hemostats

Others

Medical Hemostatic Agents Segment by Application

Hospitals

Surgical Centers

Others

Medical Hemostatic Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Hemostatic Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Medical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Medical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Medical Hemostatic Agents Industry Trends Table 2. Medical Hemostatic Agents Industry Drivers Table 3. Medical Hemostatic Agents Industry Opportunities and Challenges Table 4. Medical Hemostatic Agents Industry Restraints Table 5. Global Medical Hemostatic Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Medical Hemostatic Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Medical Hemostatic Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Medical Hemostatic Agents Sales Market Share by Manufacturers Table 9. Global Medical Hemostatic Agents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Medical Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Medical Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Medical Hemostatic Agents Manufacturers, Product Type & Application Table 13. Global Medical Hemostatic Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Hemostatic Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gelation Hemostats Table 17. Major Manufacturers of Combination Hemostats Table 18. Major Manufacturers of Others Table 19. Global Medical Hemostatic Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Medical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 21. Global Medical Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 22. Global Medical Hemostatic Agents Sales Market Share by Type (2021-2026) Table 23. Global Medical Hemostatic Agents Sales Market Share by Type (2027-2032) Table 24. Global Medical Hemostatic Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Medical Hemostatic Agents Revenue by Type (2021-2026) & (K Units) Table 26. Global Medical Hemostatic Agents Revenue by Type (2027-2032) & (K Units) Table 27. Global Medical Hemostatic Agents Revenue Market Share by Type (2021-2026) Table 28. Global Medical Hemostatic Agents Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Surgical Centers Table 31. Major Manufacturers of Others Table 32. Global Medical Hemostatic Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Medical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 34. Global Medical Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 35. Global Medical Hemostatic Agents Sales Market Share by Application (2021-2026) Table 36. Global Medical Hemostatic Agents Sales Market Share by Application (2027-2032) Table 37. Global Medical Hemostatic Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Medical Hemostatic Agents Revenue by Application (2021-2026) & (K Units) Table 39. Global Medical Hemostatic Agents Revenue by Application (2027-2032) & (K Units) Table 40. Global Medical Hemostatic Agents Revenue Market Share by Application (2021-2026) Table 41. Global Medical Hemostatic Agents Revenue Market Share by Application (2027-2032) Table 42. Global Medical Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Medical Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 44. Global Medical Hemostatic Agents Sales Market Share by Region (2021-2026) Table 45. Global Medical Hemostatic Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Medical Hemostatic Agents Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Medical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 49. North America Medical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 50. Europe Medical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 52. Europe Medical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Medical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Medical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Medical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Medical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 59. Global Medical Hemostatic Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Medical Hemostatic Agents Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Medical Hemostatic Agents Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Medical Hemostatic Agents Revenue Market Share by Region (2021-2026) Table 63. Global Medical Hemostatic Agents Revenue Market Share by Region (2027-2032) Table 64. J&J Company Information Table 65. J&J Business Overview Table 66. J&J Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. J&J Medical Hemostatic Agents Product Portfolio Table 68. J&J Recent Development Table 69. Baxter Company Information Table 70. Baxter Business Overview Table 71. Baxter Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Baxter Medical Hemostatic Agents Product Portfolio Table 73. Baxter Recent Development Table 74. BD Company Information Table 75. BD Business Overview Table 76. BD Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. BD Medical Hemostatic Agents Product Portfolio Table 78. BD Recent Development Table 79. Gelita Company Information Table 80. Gelita Business Overview Table 81. Gelita Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Gelita Medical Hemostatic Agents Product Portfolio Table 83. Gelita Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Medical Hemostatic Agents Product Portfolio Table 88. Pfizer Recent Development Table 89. B Braun Company Information Table 90. B Braun Business Overview Table 91. B Braun Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. B Braun Medical Hemostatic Agents Product Portfolio Table 93. B Braun Recent Development Table 94. CSL Behring Company Information Table 95. CSL Behring Business Overview Table 96. CSL Behring Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. CSL Behring Medical Hemostatic Agents Product Portfolio Table 98. CSL Behring Recent Development Table 99. Ferrosan Medical Devices Company Information Table 100. Ferrosan Medical Devices Business Overview Table 101. Ferrosan Medical Devices Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Ferrosan Medical Devices Medical Hemostatic Agents Product Portfolio Table 103. Ferrosan Medical Devices Recent Development Table 104. Advance Medical Solution Company Information Table 105. Advance Medical Solution Business Overview Table 106. Advance Medical Solution Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Advance Medical Solution Medical Hemostatic Agents Product Portfolio Table 108. Advance Medical Solution Recent Development Table 109. Medtronic Company Information Table 110. Medtronic Business Overview Table 111. Medtronic Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Medtronic Medical Hemostatic Agents Product Portfolio Table 113. Medtronic Recent Development Table 114. Z-Medica Company Information Table 115. Z-Medica Business Overview Table 116. Z-Medica Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Z-Medica Medical Hemostatic Agents Product Portfolio Table 118. Z-Medica Recent Development Table 119. Marine Polymer Company Information Table 120. Marine Polymer Business Overview Table 121. Marine Polymer Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Marine Polymer Medical Hemostatic Agents Product Portfolio Table 123. Marine Polymer Recent Development Table 124. Equimedical Company Information Table 125. Equimedical Business Overview Table 126. Equimedical Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Equimedical Medical Hemostatic Agents Product Portfolio Table 128. Equimedical Recent Development Table 129. CryoLife Company Information Table 130. CryoLife Business Overview Table 131. CryoLife Medical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. CryoLife Medical Hemostatic Agents Product Portfolio Table 133. CryoLife Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Medical Hemostatic Agents Distributors List Table 137. Medical Hemostatic Agents Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Medical Hemostatic Agents Product Image Figure 2. Global Medical Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Global Medical Hemostatic Agents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Medical Hemostatic Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gelation Hemostats Image Figure 9. Combination Hemostats Image Figure 10. Others Image Figure 11. Global Medical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Medical Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Medical Hemostatic Agents Sales Market Share by Type (2021-2032) Figure 14. Global Medical Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Medical Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Medical Hemostatic Agents Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Surgical Centers Image Figure 19. Others Image Figure 20. Global Medical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Medical Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Medical Hemostatic Agents Sales Market Share by Application (2021-2032) Figure 23. Global Medical Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Medical Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Medical Hemostatic Agents Revenue Market Share by Application (2021-2032) Figure 26. North America Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Medical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 28. U.S. Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Medical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 33. Germany Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Medical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 40. China Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Medical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 48. Brazil Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Medical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Medical Hemostatic Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Medical Hemostatic Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Medical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 59. North America Medical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Medical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 61. Europe Medical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Medical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Medical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Medical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Medical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Medical Hemostatic Agents Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Medical Hemostatic Agents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gelation Hemostats
  • Combination Hemostats
  • Others
Applications
  • Hospitals
  • Surgical Centers
  • Others
Companies covered
  • J&J
  • Baxter
  • BD
  • Gelita
  • Pfizer
  • B Braun
  • CSL Behring
  • Ferrosan Medical Devices
  • Advance Medical Solution
  • Medtronic
  • Z-Medica
  • Marine Polymer
  • Equimedical
  • CryoLife

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Hemostatic Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Medical Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Medical Hemostatic Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Medical Hemostatic Agents Market Dynamics
  1. 2.1 Medical Hemostatic Agents Industry Trends
  2. 2.2 Medical Hemostatic Agents Industry Drivers
  3. 2.3 Medical Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Medical Hemostatic Agents Industry Restraints
3 Medical Hemostatic Agents Market by Manufacturers
  1. 3.1 Global Medical Hemostatic Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Medical Hemostatic Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Medical Hemostatic Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Medical Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Medical Hemostatic Agents Manufacturers, Product Type & Application
  7. 3.7 Global Medical Hemostatic Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medical Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medical Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medical Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Medical Hemostatic Agents Market by Type
  1. 4.1 Medical Hemostatic Agents Type Introduction
  2. 4.1.1 Gelation Hemostats
  3. 4.1.2 Combination Hemostats
  4. 4.1.3 Others
  5. 4.2 Global Medical Hemostatic Agents Sales by Type
  6. 4.2.1 Global Medical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical Hemostatic Agents Sales by Type (2021-2032)
  8. 4.2.3 Global Medical Hemostatic Agents Sales Market Share by Type (2021-2032)
  9. 4.3 Global Medical Hemostatic Agents Revenue by Type
  10. 4.3.1 Global Medical Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Medical Hemostatic Agents Revenue by Type (2021-2032)
  12. 4.3.3 Global Medical Hemostatic Agents Revenue Market Share by Type (2021-2032)
5 Medical Hemostatic Agents Market by Application
  1. 5.1 Medical Hemostatic Agents Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Surgical Centers
  4. 5.1.3 Others
  5. 5.2 Global Medical Hemostatic Agents Sales by Application
  6. 5.2.1 Global Medical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medical Hemostatic Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Medical Hemostatic Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Medical Hemostatic Agents Revenue by Application
  10. 5.3.1 Global Medical Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Medical Hemostatic Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Medical Hemostatic Agents Revenue Market Share by Application (2021-2032)
6 Global Medical Hemostatic Agents Sales by Region
  1. 6.1 Global Medical Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Hemostatic Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Hemostatic Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Medical Hemostatic Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Medical Hemostatic Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Medical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Medical Hemostatic Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Medical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Medical Hemostatic Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Medical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Medical Hemostatic Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Medical Hemostatic Agents Revenue by Region
  1. 7.1 Global Medical Hemostatic Agents Revenue by Region
  2. 7.1.1 Global Medical Hemostatic Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Medical Hemostatic Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Medical Hemostatic Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Medical Hemostatic Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Medical Hemostatic Agents Revenue (2021-2032)
  8. 7.2.2 North America Medical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Medical Hemostatic Agents Revenue (2021-2032)
  11. 7.3.2 Europe Medical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Medical Hemostatic Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Medical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Medical Hemostatic Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Medical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 J&J
  2. 8.1.1 J&J Company Information
  3. 8.1.2 J&J Business Overview
  4. 8.1.3 J&J Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 J&J Medical Hemostatic Agents Product Portfolio
  6. 8.1.5 J&J Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Medical Hemostatic Agents Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 BD
  14. 8.3.1 BD Company Information
  15. 8.3.2 BD Business Overview
  16. 8.3.3 BD Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BD Medical Hemostatic Agents Product Portfolio
  18. 8.3.5 BD Recent Developments
  19. 8.4 Gelita
  20. 8.4.1 Gelita Company Information
  21. 8.4.2 Gelita Business Overview
  22. 8.4.3 Gelita Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Gelita Medical Hemostatic Agents Product Portfolio
  24. 8.4.5 Gelita Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Medical Hemostatic Agents Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 B Braun
  32. 8.6.1 B Braun Company Information
  33. 8.6.2 B Braun Business Overview
  34. 8.6.3 B Braun Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 B Braun Medical Hemostatic Agents Product Portfolio
  36. 8.6.5 B Braun Recent Developments
  37. 8.7 CSL Behring
  38. 8.7.1 CSL Behring Company Information
  39. 8.7.2 CSL Behring Business Overview
  40. 8.7.3 CSL Behring Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSL Behring Medical Hemostatic Agents Product Portfolio
  42. 8.7.5 CSL Behring Recent Developments
  43. 8.8 Ferrosan Medical Devices
  44. 8.8.1 Ferrosan Medical Devices Company Information
  45. 8.8.2 Ferrosan Medical Devices Business Overview
  46. 8.8.3 Ferrosan Medical Devices Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ferrosan Medical Devices Medical Hemostatic Agents Product Portfolio
  48. 8.8.5 Ferrosan Medical Devices Recent Developments
  49. 8.9 Advance Medical Solution
  50. 8.9.1 Advance Medical Solution Company Information
  51. 8.9.2 Advance Medical Solution Business Overview
  52. 8.9.3 Advance Medical Solution Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Advance Medical Solution Medical Hemostatic Agents Product Portfolio
  54. 8.9.5 Advance Medical Solution Recent Developments
  55. 8.10 Medtronic
  56. 8.10.1 Medtronic Company Information
  57. 8.10.2 Medtronic Business Overview
  58. 8.10.3 Medtronic Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medtronic Medical Hemostatic Agents Product Portfolio
  60. 8.10.5 Medtronic Recent Developments
  61. 8.11 Z-Medica
  62. 8.11.1 Z-Medica Company Information
  63. 8.11.2 Z-Medica Business Overview
  64. 8.11.3 Z-Medica Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Z-Medica Medical Hemostatic Agents Product Portfolio
  66. 8.11.5 Z-Medica Recent Developments
  67. 8.12 Marine Polymer
  68. 8.12.1 Marine Polymer Company Information
  69. 8.12.2 Marine Polymer Business Overview
  70. 8.12.3 Marine Polymer Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Marine Polymer Medical Hemostatic Agents Product Portfolio
  72. 8.12.5 Marine Polymer Recent Developments
  73. 8.13 Equimedical
  74. 8.13.1 Equimedical Company Information
  75. 8.13.2 Equimedical Business Overview
  76. 8.13.3 Equimedical Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Equimedical Medical Hemostatic Agents Product Portfolio
  78. 8.13.5 Equimedical Recent Developments
  79. 8.14 CryoLife
  80. 8.14.1 CryoLife Company Information
  81. 8.14.2 CryoLife Business Overview
  82. 8.14.3 CryoLife Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CryoLife Medical Hemostatic Agents Product Portfolio
  84. 8.14.5 CryoLife Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Hemostatic Agents Value Chain Analysis
  2. 9.1.1 Medical Hemostatic Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Hemostatic Agents Production Mode & Process
  6. 9.2 Medical Hemostatic Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Hemostatic Agents Distributors
  9. 9.2.3 Medical Hemostatic Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst